D5Z-24585-75545
3 vaccinations
10 coded responses
20 check-ins
10 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 119 / NY
- Registered
- 2021-08-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-12
Dose 1 — Pfizer-BioNTech
-
2021-08-02
Dose 2 — Pfizer-BioNTech
-
2021-08-05
Registered in v-safe
-
2021-08-05
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Swollen nymph nodesMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-06
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Swollen lymph nodesMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-08-08
- 2021-08-09
- 2021-08-16
- 2021-08-23
-
2021-08-30
Survey response — day 28, dose 2MedDRA: Fatigue, Oropharyngeal pain, SARS-CoV-2 test negative, Sneezing — Feeling: GoodFree text: Fatigue, bit of a sore throat, sneezing. Got tested and was negative for COVID.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-08
- 2021-09-17
-
2021-11-02
Survey response — 3 months, dose 2MedDRA: Brain fog, Dyspnoea, Hypertension, Office visit — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Symptoms: Uncontrolled hypertension Headaches Brain fog Quickly out of breath · Healthcare visit (other): Specialist visitsMedDRA releases: 2024-11 · check-in free text available
-
2021-11-02
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
-
2021-11-04
Call successfulReported to VAERS voluntarily prior to GDIT contact
-
2022-08-02
Dose 3 — Pfizer-BioNTech
- 2022-08-03
-
2022-08-05
Survey response — days 1–6 daily, dose 3MedDRA: Abdominal discomfort, Axillary pain, Chills, Dizziness, Lymph node pain, Nausea, Pyrexia, Self-medication — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Severe pain of underarm lymph node. /// 1st day after shot chills, fever >102 F (after Tylenol) severe lymph node pain, nausea, lightheadedness / 2nd day after shot chills, fever > 101 F (with Tylenol), severe lymph node pain, upset stomachMedDRA releases: 2024-11 · check-in free text available
-
2022-08-06
Survey response — days 1–6 daily, dose 3MedDRA: Hyperhidrosis, Lymph node pain, Lymphadenopathy, Migraine — Feeling: Poor · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Migraine, sweating, swollen and painful underarm lumph nodeMedDRA releases: 2024-11 · check-in free text available
-
2022-08-07
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Underarm lymph node is still swollen and slightly painfulMedDRA releases: 2024-11 · check-in free text available
-
2022-08-09
Survey response — day 7, dose 3MedDRA: Lymph node pain — Feeling: Good · Site: PainFree text: Mild underarm lymph node pain.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-22
Survey response — day 14, dose 3MedDRA: Brain fog, Disturbance in attention — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Brain fog, difficulty focusingMedDRA releases: 2024-11 · check-in free text available
-
2022-08-23
Survey response — day 21, dose 3MedDRA: Brain fog, Disturbance in attention — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Brain fog, difficulty focusingMedDRA releases: 2024-11 · check-in free text available
- 2022-08-30
- 2022-11-01
- 2023-02-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-12 | Pfizer-BioNTech | No |
| 2 | 2021-08-02 | Pfizer-BioNTech | No |
| 3 | 2022-08-02 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen nymph nodes
Systemic reaction (other): Swollen lymph nodes
Release 9 — day 28, dose 2
Symptoms: Fatigue, bit of a sore throat, sneezing. Got tested and was negative for COVID.
Release 10 — 3 months, dose 2
Symptoms: Uncontrolled hypertension Headaches Brain fog Quickly out of breath
Healthcare visit (other): Specialist visits
Release 12 — days 1–6 daily, dose 3
Systemic reaction (other): Severe pain of underarm lymph node. /// 1st day after shot chills, fever >102 F (after Tylenol) severe lymph node pain, nausea, lightheadedness / 2nd day after shot chills, fever > 101 F (with Tylenol), severe lymph node pain, upset stomach
Systemic reaction (other): Migraine, sweating, swollen and painful underarm lumph node
Systemic reaction (other): Underarm lymph node is still swollen and slightly painful
Release 12 — day 7, dose 3
Systemic reaction (other): Mild underarm lymph node pain.
Release 12 — day 14, dose 3
Symptoms: Brain fog, difficulty focusing
Release 12 — day 21, dose 3
Symptoms: Brain fog, difficulty focusing
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Disturbance in attention | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | ✓ | · | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | · | ✓ |
| SD | SARS-CoV-2 test negative | ✓ | · | ✓ |
| SD | Sneezing | ✓ | · | ✓ |
| SRO | Abdominal discomfort | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Chills | · | · | ✓ |
| SRO | Dizziness | · | · | ✓ |
| SRO | Hyperhidrosis | · | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | · | ✓ |
| SRO | Migraine | · | · | ✓ |
| SRO | Nausea | · | · | ✓ |
| SRO | Pyrexia | · | · | ✓ |
| SRO | Self-medication | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release